These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15213291

  • 1. Cyclic GMP and phosphodiesterase 5 inhibitor therapies: what's on the horizon?
    Lincoln TM.
    Mol Pharmacol; 2004 Jul; 66(1):11-3. PubMed ID: 15213291
    [No Abstract] [Full Text] [Related]

  • 2. Salvage techniques for phosphodiesterase 5 inhibitor therapy: purposeful but how much?
    Burnett AL.
    Eur Urol; 2006 Jul; 50(1):29-30. PubMed ID: 16567036
    [No Abstract] [Full Text] [Related]

  • 3. Optimisation of PDE5 inhibitor therapy in men with erectile dysfunction: converting "non-responders" into "responders".
    Eardley I.
    Eur Urol; 2006 Jul; 50(1):31-3. PubMed ID: 16517052
    [No Abstract] [Full Text] [Related]

  • 4. Rationale for androgens and erectile dysfunction in 2006.
    Roumeguère T.
    Eur Urol; 2006 Nov; 50(5):898-900. PubMed ID: 16893603
    [No Abstract] [Full Text] [Related]

  • 5. Emergence and success of PDE5 inhibitors as effective therapy for erectile dysfunction.
    Manganiello V.
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S1-3. PubMed ID: 15224126
    [No Abstract] [Full Text] [Related]

  • 6. [Viagra landing: the dawn of sexual science in cardiology].
    Ishikura F.
    J Cardiol; 1999 Sep; 34(3):163-7. PubMed ID: 10500978
    [No Abstract] [Full Text] [Related]

  • 7. SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction.
    Pissarnitski DA, Asberom T, Boyle CD, Chackalamannil S, Chintala M, Clader JW, Greenlee WJ, Hu Y, Kurowski S, Myers J, Palamanda J, Stamford AW, Vemulapalli S, Wang Y, Wang P, Wu P, Xu R.
    Bioorg Med Chem Lett; 2004 Mar 08; 14(5):1291-4. PubMed ID: 14980684
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
    Rosen RC, Shaw JW.
    Int J Impot Res; 2006 Mar 08; 18(6):570-1; author reply 572-3. PubMed ID: 17075585
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction.
    Bi Y, Stoy P, Adam L, He B, Krupinski J, Normandin D, Pongrac R, Seliger L, Watson A, Macor JE.
    Bioorg Med Chem Lett; 2004 Mar 22; 14(6):1577-80. PubMed ID: 15006407
    [Abstract] [Full Text] [Related]

  • 12. Rates of non-arteritic ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.
    Tsertsvadze A.
    Am J Ophthalmol; 2009 Oct 22; 148(4):625; author reply 625-6. PubMed ID: 19782802
    [No Abstract] [Full Text] [Related]

  • 13. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy.
    Lee AG, Newman NJ.
    Am J Ophthalmol; 2005 Oct 22; 140(4):707-8. PubMed ID: 16226524
    [No Abstract] [Full Text] [Related]

  • 14. Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?
    McVary KT.
    Eur Urol; 2006 Dec 22; 50(6):1153-6. PubMed ID: 17045387
    [No Abstract] [Full Text] [Related]

  • 15. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA.
    Circulation; 2007 Jul 17; 116(3):233-5. PubMed ID: 17638937
    [No Abstract] [Full Text] [Related]

  • 16. This paper continues Professor Adaikan's distinguished involvement in classical pharmacologic research of erectile physiology.
    Pickard R.
    Eur Urol; 2007 Jul 17; 52(1):259-60. PubMed ID: 17616089
    [No Abstract] [Full Text] [Related]

  • 17. [How I treat and manage erectile dysfunction in diabetics].
    Buvat J.
    Journ Annu Diabetol Hotel Dieu; 2006 Jul 17; ():185-203. PubMed ID: 17051861
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase inhibitors.
    Boswell-Smith V, Spina D, Page CP.
    Br J Pharmacol; 2006 Jan 17; 147 Suppl 1(Suppl 1):S252-7. PubMed ID: 16402111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.